The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: the FinACAF study

Association Between Bipolar Disorder or Schizophrenia and Oral Anticoagulation Use in Danish Adults With Incident or Prevalent Atrial Fibrillation

(2021) Morten Fenger-Grøn et al.   JAMA Network Open

Depression and Uptake of Oral Anticoagulation Therapy in Patients With Atrial Fibrillation

(2019) Morten Fenger-Grøn et al.   MEDICAL CARE

Contributions of specific causes of death to lost life expectancy in severe mental illness

(2017) N. Jayatilleke et al.   EUROPEAN PSYCHIATRY

Atrial fibrillation in patients with severe mental disorders and the risk of stroke, fatal thromboembolic events and bleeding: a nationwide cohort study

(2017) Mette Søgaard et al.   BMJ Open

Incidence and predictors of excessive warfarin anticoagulation in patients with atrial fibrillation—The EWA study

(2017) Samuli Jaakkola et al.   PLoS One

Incidence and Determinants of Traumatic Intracranial Bleeding Among Older Veterans Receiving Warfarin for Atrial Fibrillation

(2016) John A. Dodson et al.   JAMA Cardiology

Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder

(2015) Christoph U. Correll et al.   World Psychiatry

Mortality in Mental Disorders and Global Disease Burden Implications

(2015) Elizabeth Reisinger Walker et al.   JAMA Psychiatry

Effect of Selective Serotonin Reuptake Inhibitors on Bleeding Risk in Patients With Atrial Fibrillation Taking Warfarin

(2014) Gene R. Quinn et al.   AMERICAN JOURNAL OF CARDIOLOGY

Outcomes of Anticoagulation Therapy in Patients with Mental Health Conditions

(2014) Helen T. Paradise et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Medication nonadherence and psychiatry

(2013) Sarah C.E. Chapman et al.   CURRENT OPINION IN PSYCHIATRY

Knowledge is insufficient for self-care among heart failure patients with psychological distress.

(2013) Boyoung Hwang et al.   HEALTH PSYCHOLOGY

Identifying the Risks of Anticoagulation in Patients with Substance Abuse

(2013) Lydia M. Efird et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Are Geriatric Syndromes Associated with Reluctance to Initiate Oral Anticoagulation Therapy in Elderly Adults with Nonvalvular Atrial Fibrillation?

(2013) Bernardo Sánchez-Barba et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Excess Mortality, Causes of Death and Life Expectancy in 270,770 Patients with Recent Onset of Mental Disorders in Denmark, Finland and Sweden

(2013) Merete Nordentoft et al.   PLoS One

Atrial Fibrillation, Stroke Risk, and Warfarin Therapy Revisited

(2013) Staffan Björck et al.   STROKE

Chronic Somatic Comorbidity and Excess Mortality Due to Natural Causes in Persons with Schizophrenia or Bipolar Affective Disorder

(2011) Thomas Munk Laursen et al.   PLoS One

Review: Inequalities in healthcare provision for people with severe mental illness

(2010) David Lawrence et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA)

(2010) A. J. ROSE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

(2009) M. De Hert et al.   EUROPEAN PSYCHIATRY

Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: Systematic review and metaanalysis

(2008) David PJ Osborn et al.   BMC Psychiatry